Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EACA vs Platelet Transfusions for Bleeding Prevention in Thrombocytopenia
NCT02074436Phase 2Terminated
- Sponsor
- Emory University
- Start
- May 2014
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of aminocaproic acid in Thrombocytopenia (2 arms), sponsored by Emory University. Primary endpoint: Percentage of Participants Who Develop Major Bleeding Episodes at 6 months. Started May 2014; status: terminated.
02
Drugs
aminocaproic acid
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT02074436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02074436.